{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T21:39:09Z","timestamp":1775943549494,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010822","name":"Chengdu Science and Technology Bureau","doi-asserted-by":"publisher","award":["2024-YF05-01945-SN"],"award-info":[{"award-number":["2024-YF05-01945-SN"]}],"id":[{"id":"10.13039\/501100010822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"DOI":"10.1186\/s12969-025-01176-2","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T04:25:29Z","timestamp":1763785529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the real-world safety of Canakinumab in the treatment of systemic juvenile idiopathic arthritis in children aged 0\u201316: a comprehensive analysis based on FAERS data"],"prefix":"10.1186","volume":"23","author":[{"given":"Peng","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingqi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hejia","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"issue":"1","key":"1176_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-021-00332-8","volume":"8","author":"A Martini","year":"2022","unstructured":"Martini A, Lovell DJ, Albani S, Brunner HI, Hyrich KL, Thompson SD, et al. Juvenile idiopathic arthritis. Nat Rev Dis Primers. 2022;8(1):5.","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"1176_CR2","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41584-023-01042-z","volume":"19","author":"CH Hinze","year":"2023","unstructured":"Hinze CH, Foell D, Kessel C. Treatment of systemic juvenile idiopathic arthritis. Nat Rev Rheumatol. 2023;19(12):778\u201389.","journal-title":"Nat Rev Rheumatol"},{"key":"1176_CR3","doi-asserted-by":"publisher","first-page":"583513","DOI":"10.3389\/fimmu.2020.583513","volume":"11","author":"JY Jung","year":"2020","unstructured":"Jung JY, Kim JW, Suh CH, Kim HA. Roles of interactions between Toll-Like receptors and their endogenous ligands in the pathogenesis of systemic juvenile idiopathic arthritis and Adult-Onset still\u2019s disease. Front Immunol. 2020;11:583513.","journal-title":"Front Immunol"},{"key":"1176_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/1744666X.2019.1707664","volume":"16","author":"P Sfriso","year":"2020","unstructured":"Sfriso P, Bindoli S, Doria A, Feist E, Galozzi P. Canakinumab for the treatment of adult-onset still\u2019s disease. Expert Rev Clin Immunol. 2020;16:129\u201338.","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"1176_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4161\/mabs.2.1.10328","volume":"2","author":"E Dhimolea","year":"2010","unstructured":"Dhimolea E. Canakinumab MAbs. 2010;2(1):3\u201313.","journal-title":"Canakinumab MAbs"},{"key":"1176_CR6","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1080\/07853890.2022.2095431","volume":"54","author":"WG Ambler","year":"2022","unstructured":"Ambler WG, Nanda K, Onel KB, Shenoi S. Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives. Ann Med. 2022;54:1839\u201350.","journal-title":"Ann Med"},{"key":"1176_CR7","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","volume":"367","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, et al. Two randomized trials of Canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367:2396\u2013406.","journal-title":"N Engl J Med"},{"key":"1176_CR8","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1136\/annrheumdis-2018-213150","volume":"77","author":"N Ruperto","year":"2018","unstructured":"Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, et al. Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials. Ann Rheum Dis. 2018;77:1710\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1176_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12969-017-0147-3","volume":"15","author":"B H\u00fcgle","year":"2017","unstructured":"H\u00fcgle B, Speth F, Haas JP. Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2017;15(1):16.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1176_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/DHPS.S391857","volume":"15","author":"TA Simon","year":"2023","unstructured":"Simon TA, Simon JH, Heaning EG, Gomez-Caminero A, Marcu JP. Delta-8, a Cannabis-Derived tetrahydrocannabinol isomer: evaluating case report data in the food and drug administration adverse event reporting system (FAERS) database. Drug Healthc Patient Saf. 2023;15:25\u201338.","journal-title":"Drug Healthc Patient Saf"},{"key":"1176_CR11","doi-asserted-by":"publisher","first-page":"101967","DOI":"10.1016\/j.eclinm.2023.101967","volume":"59","author":"C Zhou","year":"2023","unstructured":"Zhou C, Peng S, Lin A, Jiang A, Peng Y, Gu T, et al. Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database. EClinicalMedicine. 2023;59:101967.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"1176_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jaccao.2021.01.009","volume":"3","author":"JZ Ye","year":"2021","unstructured":"Ye JZ, Hansen FB, Mills RW, Lundby A. Oncotherapeutic protein kinase inhibitors associated with Pro-Arrhythmic liability. JACC CardioOncol. 2021;3(1):88\u201397.","journal-title":"JACC CardioOncol"},{"key":"1176_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"EG Brown","year":"1999","unstructured":"Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf. 1999;20:109\u201317.","journal-title":"Drug Saf"},{"key":"1176_CR14","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2147\/CLEP.S365513","volume":"14","author":"Y Shu","year":"2022","unstructured":"Shu Y, He X, Liu Y, Wu P, Zhang Q. A Real-World disproportionality analysis of olaparib: data mining of the public version of FDA adverse event reporting system. Clin Epidemiol. 2022;14:789\u2013802.","journal-title":"Clin Epidemiol"},{"key":"1176_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2165\/11599740-000000000-00000","volume":"35","author":"VR Cornelius","year":"2012","unstructured":"Cornelius VR, Sauzet O, Evans SJ. A signal detection method to detect adverse drug reactions using a parametric time-to-event model in simulated cohort data. Drug Saf. 2012;35:599\u2013610.","journal-title":"Drug Saf"},{"issue":"2","key":"1176_CR16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s40744-021-00422-9","volume":"9","author":"C Dunger-Baldauf","year":"2022","unstructured":"Dunger-Baldauf C, Nakasato P, Noviello S, Whelan S, Bieth B. Similar clinical outcomes in patients with systemic juvenile idiopathic arthritis and Adult-Onset still\u2019s disease treated with canakinumab: bayesian and population Model-Based analyses. Rheumatol Ther. 2022;9(2):753\u201362.","journal-title":"Rheumatol Ther"},{"issue":"8","key":"1176_CR17","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.3390\/ijms23084119","volume":"23","author":"DA Hart","year":"2022","unstructured":"Hart DA. Sex differences in biological systems and the conundrum of menopause: potential commonalities in Post-Menopausal disease mechanisms. Int J Mol Sci. 2022;23(8):4119.","journal-title":"Int J Mol Sci"},{"key":"1176_CR18","doi-asserted-by":"publisher","first-page":"665028","DOI":"10.3389\/fmed.2021.665028","volume":"8","author":"DW Nada","year":"2021","unstructured":"Nada DW, Moghazy A, Allam AE, Alunno A, Ibrahim AM. Short-Term outcomes and predictors of effectiveness of Tocilizumab in systemic juvenile idiopathic arthritis: A prospective cohort study. Front Med (Lausanne). 2021;8:665028.","journal-title":"Front Med (Lausanne)"},{"key":"1176_CR19","doi-asserted-by":"publisher","first-page":"894846","DOI":"10.3389\/fped.2022.894846","volume":"10","author":"MM Kostik","year":"2022","unstructured":"Kostik MM, Isupova EA, Belozerov K, Likhacheva TS, Suspitsin EN, Raupov R, et al. Standard and increased Canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis. Front Pediatr. 2022;10:894846.","journal-title":"Front Pediatr"},{"key":"1176_CR20","first-page":"842","volume":"61","author":"XN Zhu","year":"2023","unstructured":"Zhu XN, He TY, Luo SL, Huang YY, Xu YB, Liu SL, et al. [Refractory macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis treated with Canakinumab]. Zhonghua Er Ke Za Zhi. 2023;61:842\u20134.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"6","key":"1176_CR21","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/art.42808","volume":"76","author":"T Miyamoto","year":"2024","unstructured":"Miyamoto T, Izawa K, Masui S, Yamazaki A, Yamasaki Y, Matsubayashi T, et al. Clinical characteristics of Cryopyrin-Associated periodic syndrome and Long-Term Real-World efficacy and tolerability of Canakinumab in japan: results of a nationwide survey. Arthritis Rheumatol. 2024;76(6):949\u201362.","journal-title":"Arthritis Rheumatol"},{"issue":"17","key":"1176_CR22","doi-asserted-by":"publisher","first-page":"8570","DOI":"10.7150\/thno.62046","volume":"11","author":"L Tong","year":"2021","unstructured":"Tong L, Hao H, Zhang Z, Lv Y, Liang X, Liu Q, et al. Milk-derived extracellular vesicles alleviate ulcerative colitis by regulating the gut immunity and reshaping the gut microbiota. Theranostics. 2021;11(17):8570\u201386.","journal-title":"Theranostics"},{"issue":"24","key":"1176_CR23","doi-asserted-by":"publisher","first-page":"7471","DOI":"10.1182\/bloodadvances.2023011578","volume":"7","author":"J Woo","year":"2023","unstructured":"Woo J, Lu D, Lewandowski A, Xu H, Serrano P, Healey M, et al. Effects of IL-1\u03b2 Inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial. Blood Adv. 2023;7(24):7471\u201384.","journal-title":"Blood Adv"},{"key":"1176_CR24","volume-title":"Clinical and research information on Drug-Induced liver injury","author":"LiverTox","year":"2012","unstructured":"LiverTox. Clinical and research information on Drug-Induced liver injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012."},{"key":"1176_CR25","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/art.40146","volume":"69","author":"JI Arostegui","year":"2017","unstructured":"Arostegui JI, Anton J, Calvo I, Robles A, Iglesias E, L\u00f3pez-Montesinos B, et al. Phase II study to assess the efficacy and safety of Canakinumab treatment in active hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheumatol. 2017;69:1679\u201388.","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"1176_CR26","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1093\/rheumatology\/keaa814","volume":"60","author":"H Nagai","year":"2021","unstructured":"Nagai H, Kirino Y, Nakano H, Kunishita Y, Henmi R, Szymanski AM, et al. Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset still\u2019s disease. Rheumatology (Oxford). 2021;60(8):3888\u201395.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1176_CR27","doi-asserted-by":"publisher","first-page":"e002611","DOI":"10.1136\/rmdopen-2022-002611","volume":"9","author":"M Macaraeg","year":"2023","unstructured":"Macaraeg M, Schulert GS. Complications of complications: diagnosis and treatment of recurrent macrophage activation syndrome in a patient with well-controlled systemic juvenile idiopathic arthritis. RMD Open. 2023;9(1):e002611.","journal-title":"RMD Open"},{"issue":"Suppl 1","key":"1176_CR28","doi-asserted-by":"publisher","first-page":"P56","DOI":"10.1186\/1546-0096-12-S1-P56","volume":"12","author":"L Cifaldi","year":"2014","unstructured":"Cifaldi L, Prencipe G, Caiello I, Bracaglia C, Strippoli R, De Benedetti F. Inhibition of natural killer (nk) cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome. Pediatr Rheumatol Online J. 2014;12(1):P56.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1162","key":"1176_CR29","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/postgradmedj-2021-139832","volume":"98","author":"A Israel","year":"2022","unstructured":"Israel A, Bornstein G, Gilad L, Shechtman L, Furie N, Ben-Zvi I, et al. Clinical and prognostic significance of elevated ferritin levels in hospitalised adults. Postgrad Med J. 2022;98(1162):622\u20135.","journal-title":"Postgrad Med J"},{"issue":"3","key":"1176_CR30","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/all.15072","volume":"77","author":"A Schr\u00f6der","year":"2022","unstructured":"Schr\u00f6der A, Lunding LP, Zissler UM, Vock C, Webering S, Ehlers JC, et al. IL-37 regulates allergic inflammation by counterbalancing pro-inflammatory IL-1 and IL-33. Allergy. 2022;77(3):856\u201369.","journal-title":"Allergy"},{"issue":"1","key":"1176_CR31","doi-asserted-by":"publisher","first-page":"6451","DOI":"10.1038\/s41598-020-63410-z","volume":"10","author":"W Pietka","year":"2020","unstructured":"Pietka W, Sundnes O, Hammarstr\u00f6m C, Zucknick M, Khnykin D, Haraldsen G. Lack of interleukin-33 and its receptor does not prevent calcipotriol-induced atopic dermatitis-like inflammation in mice. Sci Rep. 2020;10(1):6451.","journal-title":"Sci Rep"},{"issue":"3","key":"1176_CR32","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3390\/jcm12031191","volume":"12","author":"M Tanczosova","year":"2023","unstructured":"Tanczosova M, Hugo J, Gkalpakiotis S. Treatment of severe atopic dermatitis with dupilumab in patients with advanced cancer. J Clin Med. 2023;12(3):1191.","journal-title":"J Clin Med"},{"issue":"7","key":"1176_CR33","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3390\/nu14071476","volume":"14","author":"B Tian","year":"2022","unstructured":"Tian B, Zhao Q, Xing H, Xu J, Li Z, Zhu H, et al. Gastroprotective effects of ganoderma lucidum polysaccharides with different molecular weights on Ethanol-Induced acute gastric injury in rats. Nutrients. 2022;14(7):1476.","journal-title":"Nutrients"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-025-01176-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-025-01176-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-025-01176-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T19:03:12Z","timestamp":1767034992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12969-025-01176-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1176"],"URL":"https:\/\/doi.org\/10.1186\/s12969-025-01176-2","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval was required for this research, and there are no conflicts of interest to declare. The data used in this study are publicly available and do not involve any proprietary or confidential information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}